HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Sebaceous Cell Carcinoma

Sebaceous cell carcinoma (SCC) is a rare and aggressive form of skin cancer that originates in the sebaceous glands, which are responsible for producing the skin's natural oils. These glands are found in the hair follicles throughout the body. SCC typically develops in areas with a high concentration of these glands, such as the eyelids. Unlike other types of skin cancer, sebaceous cell carcinoma often presents as a painless, slow-growing lump or nodule. It can also manifest as a yellowish or reddish lesion on the skin. Due to its subtle and non-specific symptoms, diagnosis may be delayed, leading to the cancer advancing to a more aggressive stage. SCC is known for its potential to spread to surrounding tissues and lymph nodes, making early detection crucial for effective treatment. Surgical removal is the primary treatment, and in some cases, additional therapies such as radiation or chemotherapy may be recommended. Risk factors for sebaceous cell carcinoma include age, with the condition most commonly affecting individuals over the age of 60. People with a history of radiation exposure or certain genetic syndromes, such as Muir-Torre syndrome, are also at an increased risk. Regular skin examinations and prompt medical attention for any suspicious changes or growths on the skin are essential for early detection and improved prognosis. As with many cancers, prevention includes sun protection measures such as sunscreen use and avoiding excessive sun exposure. In conclusion, sebaceous cell carcinoma is a rare but potentially aggressive form of skin cancer that originates in the sebaceous glands. Early detection is crucial for successful treatment, and individuals at higher risk should undergo regular skin examinations. As with many types of skin cancer, preventive measures such as sun protection play a significant role in minimizing the risk of development.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp